Article Abstract:
Competition within the biotech industry is growing and there are more United States firms biding attention each year, where competition is increasingly becoming global, as companies from Europe and the Pacific Rim seek notice from US and other international biotech audiences. As a result, it has become increasingly important for a company to clearly differentiate itself from its peers and to raise its level of visibility above the general crowd, which only be achieved through media relations.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
A study demonstrated that commercialization efforts are significant, with more than 150 startups and small and medium enterprises (SMEs) pursuing focused nanomedicine R&D projects and 38 nanotechnology-enabled products currently on the market with total sales valued at $6.8 billion. Drug delivery applications in 2006 dominate nanomedicine, accounting for three-quarters of the research activity and of the nanomedicine market.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
The market trends for the biotechnology products are examined to find the reason behind the success and failure of biotech drugs. An analysis of the U.S. sales of biotechnology drugs helps in understanding the categories and factors that are responsible for the high growth of the biotech sector.
User Contributions:
Comment about this article or add new information about this topic: